SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Blueprint Medicines Corporation (BPMC)

BPMC RSS Feed
Add BPMC Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/5/2016 12:43:36 PM - Followers: 6 - Board type: Free - Posts Today: 0

Blueprint Medicines is a patient-driven oncology company developing highly selective kinase inhibitors for genomically defined cancer subsets. Led by a management team and advisors with world-renowned expertise in cancer genomics, drug discovery and clinical oncology, Blueprint has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling Blueprint to rapidly develop potent highly selective compounds against clear genomic driver targets.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BPMC
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BPMC News: Blueprint Medicines to Present New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointest... 05/17/2017 05:01:00 PM
BPMC News: Amended Statement of Ownership (sc 13g/a) 05/03/2017 05:25:22 PM
BPMC News: Quarterly Report (10-q) 05/03/2017 04:34:02 PM
BPMC News: Current Report Filing (8-k) 05/03/2017 07:33:52 AM
BPMC News: Blueprint Medicines Reports First Quarter 2017 Financial Results 05/03/2017 07:00:00 AM